NCT05275478 2026-04-15
Safety and Tolerability of TNG908 in Patients With MTAP-deleted Solid Tumors
Tango Therapeutics, Inc.
Phase 1/2 Terminated
Tango Therapeutics, Inc.
Institut Claudius Regaud
Institut Cancerologie de l'Ouest
Hutchmed
University of Wisconsin, Madison
Wake Forest University Health Sciences
M.D. Anderson Cancer Center